NYSE:ELANPharmaceuticals
Is Elanco (ELAN) Quietly Reframing Its Pet Therapeutics Strategy With This Kansas Antibody Expansion?
Elanco Animal Health has completed a 25,000-square-foot, US$120 million manufacturing expansion at its Elwood, Kansas site, quadrupling monoclonal antibody capacity and adding a pilot plant, new quality control lab and support spaces, with a further US$30 million warehousing investment planned through 2028.
This enlarged facility underpins production of Elanco’s new monoclonal antibody treatments Befrena and Trutect, reinforcing its push into advanced pet therapeutics as pet owners demand...